Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3 Study to Evaluate the Safety and Efficacy of Dexlansoprazole MR (60 mg QD and 90 mg QD) Compared to Placebo in Maintenance of Healing in Subjects With Healed Erosive Esophagitis

NCT00255151 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT00255151
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00255151 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3 Study to Evaluate the Safety and Efficacy of Dexlansoprazole MR (60 mg QD and 90 mg QD) Compared to Placebo in Maintenance of Healing in Subjects With Healed Erosive Esophagitis
Lead sponsor
Takeda
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2006
Completion date
November 30, 2006
Enrollment
451 (actual)
Sites
100

Conditions

As the registry lists them; a condition with its own page is linked.

esophagitis, peptic, esophagitis, reflux